- Saturday
- May 8th, 2021
FitManitoba
PARIS, FRANCE -- Taking anti-inflammatory drugs like ibuprofen does not increase the risk of developing a severe form of COVID-19 or of dying from it, according to a new study, the largest so far on this class of medicines. At...
By discovering a potential new cellular mechanism for migraines, researchers may have also found a new way to treat chronic migraine. Amynah Pradhan, associate professor of psychiatry at the University of Illinois Chicago, is the senior author of the study,...
Researchers have created a probe that glows when it detects an enzyme associated with issues that can lead to blood clots and strokes. The team of researchers, from the Department of Chemistry and the National Lung and Heart Institute at...
Nearly 1 in 5 adults with high blood pressure, a leading risk factor for heart disease and stroke, also take a medicine that could be elevating their blood pressure, according to new research presented at the American College of Cardiology's...
Moderate alcohol intake -- defined as no more than one alcoholic drink for women and two for men per day -- has been associated with a lower risk of dying from cardiovascular disease when compared with individuals who abstain from...
It turns out that not all build-ups of tau protein are bad, and a team of researchers from the Perelman School of Medicine at the University of Pennsylvania developed a method to show that. Using mammalian cell models, the researchers...
A study designed to enroll an equal number of Black and white men with advanced prostate cancer confirms key findings that have been evident in retrospective analyses and suggest potential new avenues for treating Black patients who disproportionately die of...
The latest:Manitoba is closing a number of business and services and limiting gatherings in order to address the third wave of COVID-19 in the province, while Nova Scotia tightened its border restrictions amid record case numbers. Dr. Brent Roussin, Manitoba's chief provincial public health...
A team of researchers at the Center for Bioactive Delivery at the University of Massachusetts Amherst's Institute for Applied Life Sciences has engineered a nanoparticle that has the potential to revolutionize disease treatment, including for cancer. This new research, which...
Early in human development, during the first trimester of gestation, a fetus may have XX or XY chromosomes that indicate its sex. Yet at this stage a mass of cells known as the bipotential gonad that ultimately develops into either...
Loading posts... 
All posts loaded
No more posts